Literature DB >> 19220056

Identification of protonated oxygenic ligands of ribonucleotide reductase intermediate X.

Muralidharan Shanmugam1, Peter E Doan, Nicholas S Lees, Joanne Stubbe, Brian M Hoffman.   

Abstract

We previously used a combination of continuous-wave (CW) and pulsed electron-nuclear double resonance (ENDOR) protocols to identify the types of protonated oxygen (OH(x)) species and their disposition within the Fe(III)/Fe(IV) cluster of intermediate X, the direct precursor of the essential diferric-tyrosyl radical cofactor of the beta2 subunit of Escherichia coli ribonucleotide reductase (RNR). We concluded that X contains the [(H(x)O)Fe(III)OFe(IV)] fragment (T model), and does not contain a mu-hydroxo bridge. When combined with a subsequent (17)O ENDOR study of X prepared with H(2)(17)O and with (17)O(2), the results led us to suggest that this fragment is the entire inorganic core of X. This has been questioned by recent reports, but these reports do not themselves agree on the core of X. One concluded that X possesses a di-mu-oxo Fe(III)/Fe(IV) core plus a terminal (H(2)O) bound to Fe(III) [e.g., Han, W.-G.; Liu, T.; Lovell, T.; Noodleman, L. J. Am. Chem. Soc. 2005, 127, 15778-15790]. The other [Mitic, N.; Clay, M. D.; Saleh, L.; Bollinger, J. M.; Solomon, E. I. J. Am. Chem. Soc. 2007, 129, 9049-9065] concluded that X contains only a single oxo bridge and postulated the presence of an additional hydroxo bridge plus a terminal hydroxyl bound to Fe(III). In this report we take advantage of improvements in 35 GHz pulsed ENDOR performance to reexamine the protonation state of oxygenic ligands of the inorganic core of X by directly probing the exchangeable proton(s) with (2)H pulsed ENDOR spectroscopy. These (2)H ENDOR measurements confirm that X contains an Fe(III)-bound terminal aqua ligand (H(x)O), but the spectra contain none of the features that would be required for the proton of a bridging hydroxyl. Thus, we confirm that X contains a terminal aqua (most likely hydroxo) ligand to Fe(III) in addition to one or two mu-oxo bridges but does not contain a mu-hydroxo bridge. The (2)H ENDOR measurements further demonstrate that this conclusion is applicable to both wild type and Y122F-beta2 mutant, and in fact we detect no difference between the properties of protons on the terminal oxygens in the two variants; likewise, (14)N ENDOR measurements of histidyl ligands bound to Fe show no difference between the two variants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220056      PMCID: PMC2789976          DOI: 10.1021/ja809223s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

Review 1.  Structure and function of the radical enzyme ribonucleotide reductase.

Authors:  H Eklund; U Uhlin; M Färnegårdh; D T Logan; P Nordlund
Journal:  Prog Biophys Mol Biol       Date:  2001-11       Impact factor: 3.667

2.  Geometric and electronic structure/function correlations in non-heme iron enzymes.

Authors:  E I Solomon; T C Brunold; M I Davis; J N Kemsley; S K Lee; N Lehnert; F Neese; A J Skulan; Y S Yang; J Zhou
Journal:  Chem Rev       Date:  2000-01-12       Impact factor: 60.622

Review 3.  ENDOR of metalloenzymes.

Authors:  Brian M Hoffman
Journal:  Acc Chem Res       Date:  2003-07       Impact factor: 22.384

4.  Improving W-band pulsed ENDOR sensitivity--random acquisition and pulsed special TRIPLE.

Authors:  B Epel; D Arieli; D Baute; D Goldfarb
Journal:  J Magn Reson       Date:  2003-09       Impact factor: 2.229

Review 5.  Electron-nuclear double resonance spectroscopy (and electron spin-echo envelope modulation spectroscopy) in bioinorganic chemistry.

Authors:  Brian M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

6.  Characterization of Y122F R2 of Escherichia coli ribonucleotide reductase by time-resolved physical biochemical methods and X-ray crystallography.

Authors:  W Tong; D Burdi; P Riggs-Gelasco; S Chen; D Edmondson; B H Huynh; J Stubbe; S Han; A Arvai; J Tainer
Journal:  Biochemistry       Date:  1998-04-28       Impact factor: 3.162

7.  Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme.

Authors:  C L Atkin; L Thelander; P Reichard; G Lang
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

8.  Spectroscopic and electronic structure studies of intermediate X in ribonucleotide reductase R2 and two variants: a description of the FeIV-oxo bond in the FeIII-O-FeIV dimer.

Authors:  Natasa Mitić; Michael D Clay; Lana Saleh; J Martin Bollinger; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2007-06-29       Impact factor: 15.419

9.  Electronic and spectroscopic studies of the non-heme reduced binuclear iron sites of two ribonucleotide reductase variants: comparison to reduced methane monooxygenase and contributions to O2 reactivity.

Authors:  Pin-Pin Wei; Andrew J Skulan; Natasa Mitić; Yi-Shan Yang; Lana Saleh; J Martin Bollinger; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

10.  Identification of the stable free radical tyrosine residue in ribonucleotide reductase.

Authors:  A Larsson; B M Sjöberg
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  27 in total

1.  A hot oxidant, 3-NO2Y122 radical, unmasks conformational gating in ribonucleotide reductase.

Authors:  Kenichi Yokoyama; Ulla Uhlin; JoAnne Stubbe
Journal:  J Am Chem Soc       Date:  2010-11-03       Impact factor: 15.419

2.  A comparison of two-electron chemistry performed by the manganese and iron heterodimer and homodimers.

Authors:  Katarina Roos; Per E M Siegbahn
Journal:  J Biol Inorg Chem       Date:  2011-11-15       Impact factor: 3.358

3.  O(2)-evolving chlorite dismutase as a tool for studying O(2)-utilizing enzymes.

Authors:  Laura M K Dassama; Timothy H Yosca; Denise A Conner; Michael H Lee; Béatrice Blanc; Bennett R Streit; Michael T Green; Jennifer L DuBois; Carsten Krebs; J Martin Bollinger
Journal:  Biochemistry       Date:  2012-02-13       Impact factor: 3.162

Review 4.  Proton-coupled electron transfer.

Authors:  My Hang V Huynh; Thomas J Meyer
Journal:  Chem Rev       Date:  2007-11       Impact factor: 60.622

5.  EXAFS simulation refinement based on broken-symmetry DFT geometries for the Mn(IV)-Fe(III) center of class I RNR from Chlamydia trachomatis.

Authors:  Sandra Luber; Sophie Leung; Carmen Herrmann; Wenge Han Du; Louis Noodleman; Victor S Batista
Journal:  Dalton Trans       Date:  2014-01-14       Impact factor: 4.390

Review 6.  Metallation and mismetallation of iron and manganese proteins in vitro and in vivo: the class I ribonucleotide reductases as a case study.

Authors:  Joseph A Cotruvo; Joanne Stubbe
Journal:  Metallomics       Date:  2012-09-18       Impact factor: 4.526

7.  Evidence for a Di-μ-oxo Diamond Core in the Mn(IV)/Fe(IV) Activation Intermediate of Ribonucleotide Reductase from Chlamydia trachomatis.

Authors:  Ryan J Martinie; Elizabeth J Blaesi; Carsten Krebs; J Martin Bollinger; Alexey Silakov; Christopher J Pollock
Journal:  J Am Chem Soc       Date:  2017-01-27       Impact factor: 15.419

Review 8.  Assembly of nonheme Mn/Fe active sites in heterodinuclear metalloproteins.

Authors:  Julia J Griese; Vivek Srinivas; Martin Högbom
Journal:  J Biol Inorg Chem       Date:  2014-04-26       Impact factor: 3.358

9.  A 2.8 Å Fe-Fe separation in the Fe2(III/IV) intermediate, X, from Escherichia coli ribonucleotide reductase.

Authors:  Laura M K Dassama; Alexey Silakov; Courtney M Krest; Julio C Calixto; Carsten Krebs; J Martin Bollinger; Michael T Green
Journal:  J Am Chem Soc       Date:  2013-10-31       Impact factor: 15.419

10.  DFT calculations of comparative energetics and ENDOR/Mössbauer properties for two protonation states of the iron dimer cluster of ribonucleotide reductase intermediate X.

Authors:  Wen-Ge Han; Louis Noodleman
Journal:  Dalton Trans       Date:  2009-06-23       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.